HCA Healthcare on Pace for Largest Percent Decrease Since October 2022 — Data Talk
HCA Healthcare Inc (HCA) is currently at $326.76, down $16.53 or 4.82%
--Would be lowest close since May 29, 2024, when it closed at $325.13
--On pace for largest percent decrease since Oct. 21, 2022, when it fell 5.73%
--Snaps a two-day winning streak
--Down 3.82% month-to-date; on pace for worst month since April 2024, when it fell 7.11%
--Up 20.72% year-to-date
--Down 4.82% from its all-time closing high of $343.29 on June 27, 2024
--Up 7.67% from 52 weeks ago (June 30, 2023), when it closed at $303.48
--Down 4.82% from its 52-week closing high of $343.29 on June 27, 2024
--Up 47.32% from its 52-week closing low of $221.81 on Oct. 26, 2023
--Traded as low as $326.52; lowest intraday level since May 29, 2024, when it hit $315.20
--Down 4.89% at today's intraday low; largest intraday percent decrease since April 26, 2024, when it fell as much as 5.84%
--Third worst performer in the S&P 500 today
All data as of 11:12:54 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 28, 2024 11:29 ET (15:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations